Anyang, South Korea

Je Hak Kim

This inventor holds 1 USPTO granted patent. Top assignees: Cmg Pharmaceutical Co., Ltd., Handok Inc.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Je Hak Kim. Retrieved from https://idiyas.com/inventor/je-hak-kim-cj2puhj1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Je Hak Kim: Innovator in Trk Inhibitors

Introduction

Je Hak Kim is a prominent inventor based in Anyang, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel chemical compounds. His work focuses on creating innovative solutions for various medical conditions.

Latest Patents

One of Je Hak Kim's notable patents is for "Fused ring heteroaryl compounds and their use as Trk inhibitors." This patent discloses novel chemical compounds represented by Formula I or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer, or prodrug thereof. The compounds can be utilized as inhibitors of Trk and are beneficial in treating pain, cancer, inflammation, neurodegenerative diseases, and certain infectious diseases.

Career Highlights

Throughout his career, Je Hak Kim has worked with reputable companies such as Cmg Pharmaceutical Co., Ltd. and Handok Inc. His expertise in the pharmaceutical industry has allowed him to contribute to the advancement of medical treatments and therapies.

Collaborations

Je Hak Kim has collaborated with notable colleagues, including Moonsoo Kim and Chaewoon Lee. These partnerships have fostered innovation and have been instrumental in the development of his patented compounds.

Conclusion

Je Hak Kim's work in the field of Trk inhibitors showcases his dedication to advancing medical science. His innovative compounds hold promise for treating various diseases, highlighting the importance of his contributions to the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…